Women with type 2 diabetes should consider switching their HRT tablets to patches to reduce their risk of potentially fatal blood clots, according to a new study. Researchers have found women with the condition who take an oral form of HRT have double the risk of a pulmonary embolism - when a blood clot blocks an artery in the lung - than those using skin patches. They also have a 21 per cent increased risk of heart disease, the study revealed.
A new drug baxdrostat can significantly lower blood pressure in these people whose levels remain dangerously high despite taking several medicines. The results of the BaxHTN study showed that after 12 weeks, patients taking baxdrostat saw their blood pressure fall by about 9-10 mmHg (millimetres of mercury, the unit of measurement of blood pressure) more than the placebo a reduction large enough to cut cardiovascular risk.